The migration inhibition technique has been used to study delayed hypersensitivity in vitro by using peritoneal exudate cells and splenic lymphocytes from mice vaccinated with viable cells of the attenuated H37Ra strain of Mycobacterium tuberculosis and from mice vaccinated with ribonucleic acid (myc RNA) preparations obtained from viable mycobacterial cells of the same strain.
The migration inhibition technique has been used to study delayed hypersensitivity in vitro by using peritoneal exudate cells and splenic lymphocytes from mice vaccinated with viable cells of the attenuated H37Ra strain of Mycobacterium tuberculosis and from mice vaccinated with ribonucleic acid (myc RNA) preparations obtained from viable mycobacterial cells of the same strain.
Inhibition of macrophage migration was noted when purified protein derivative (PPD) or viable H37Ra cells were added to peritoneal exudate cells obtained from mice immunized with viable H37Ra cells and not from mice immunized with myc RNA. Splenic lymphocyte cultures were exposed to the same antigens in vitro. Filtered supernatant fluids from these lymphocyte cultures, when added to peritoneal exudate cells obtained from nonimmunized mice, inhibited migration only when they were obtained from lymphocytes which came from mice immunized with viable H37Ra cells. Injection of PPD intravenously into vaccinated mice resulted in inhibitory supernatant fluids from splenic lymphocyte cultures only when the lymphocytes came from mice immunized with viable H37Ra cells. However, intravenous injection of either viable H37Ra cells or of myc RNA preparations into mice vaccinated with myc RNA occasionally produced inhibitory supernatant fluids when lymphocytes were obtained from these mice. On the other hand, mice vaccinated with myc RNA or viable H37Ra cell preparations were consistently and equally protected against intravenous challenge with the virulent H37Rv strain. Thus, although some evidence was obtained for a delayed type hypersensitivity in mice vaccinated with H37Ra cells or with myc RNA to ribosomal proteins or other proteins associated with the RNA preparation, no evidence of tuberculin hypersensitivity could be detected in any mice vaccinated with the myc RNA. These results argue against a role for tuberculin hypersensitivity in immunity to tuberculous infection.
The relationship between tuberculin hypersensitivity and cellular immunity to infection has not been fully resolved. The close association of the two phenomena in animals vaccinated with viable attenuated mycobacterial cells has suggested to some that tuberculin hypersensitivity may be responsible for the increased resistance to infection with virulent tubercle bacilli in vaccinated animals (5, 6) . However, evidence is available which indicates that the two phenomena can be dissociated. For example, tuberculin hypersensitivity has been produced without a concurrent increase in resistance (9) . Also, in immunized animals a reduction in tuberculin hypersensitivity by de- sensitization has been achieved without a loss of immunity to infection (10) . Furthermore, a mycobacterial ribonucleic acid (myc RNA) preparation has been isolated from viable cells of the attenuated H37Ra strain which will immunize mice as effectively as the living H37Ra cells do (13, 15) without inducing tuberculin hypersensitivity in guinea pigs or mice (18, 19) .
Youmans and Youmans (17, 19) have proposed a multiple-response theory of immunity to tuberculosis. The work of Youmans and Youmans (13, 19) and Coppel and Youmans (2, 3, 4) indicates that the major immune response in this disease is specific and that the agent responsible can be found in the RNA fraction (13, 5) . Secondly, immunity to tuberculosis depends, in part, on relatively stable substances (some of which can induce tuberculin hypersensitivity) which will bring about a moderate amount of nonspecific immunity to infection because of stimulation of a granulomatous response or by activation of macrophages (17, 19) .
Mackaness (6) states that failure to demonstrate dermal hypersensitivity after vaccination with a particular preparation is not a valid argument against the existence of a hypersensitive state, especially because it frequently can be demonstrated that in anergic animals a rapid appearance of dermal hypersensitivity can be noted after a second antigen stimulation. According to this view, the so-called "nonsensitizing" components merely produce very low nondetectable degrees of tuberculin hypersensitivity. This hypersensitivity would be rapidly boosted upon challenge of the animal with virulent tubercle bacilli.
Most of the work done with myc RNA vaccine has been performed in mice. Methods available for the detection of tuberculin hypersensitivity in mice are generally poor, although dermal sensitivity can be noted after injection of tuberculin into footpads of mice vaccinated with H37Ra cells. However, recent evidence suggests that the ability of sensitized lymphocytes to react in vitro when exposed to antigen is a more sensitive measure of hypersensitivity than is dermal reactivity (11) .
In guinea pigs, the macrophage migrationinhibition technique is an in vitro correlate of delayed hypersensitivity. In a previous investigation we have shown that this technique can be readily adapted for use with mouse lymphocytes (7) . Under appropriate conditions the production of migration inhibitory factor (MIF) by stimulated mouse lymphocytes also can be readily demonstrated (7). Therefore it is now possible, by using this more sensitive technique for the detection of tuberculin hypersensitivity, to more accurately compare the immune response of mice with their state of tuberculin hypersensitivity after vaccination with intact viable H37Ra cells or with myc RNA preparations.
MATERIALS AND METHODS
Mice. Male outbred CF-1 (Carworth Farms) and inbred C57BI/6 (ARS/Sprague-Dawley) mice, weighing 18 to 22 g, were used throughout. Mice were housed 10 per cage and allowed unlimited food and water.
Vaccination. Vaccination with viable H37Ra cells was carried out as previously described (7) by giving intraperitoneal or subcutaneous injections of 1 mg, (moist weight) of H37Ra cells in 0.2 ml of 0.01 M phosphate buffer, pH 7.0.
Immunogenic myc RNA, prepared from viable H37Ra cells, was isolated by the methods described by Youmans and Youmans (13, 15) . Briefly, a particulate fraction was obtained by differential centrifugation of ruptured viable H37Ra cells. Ribosomes were obtained after treatment of the particulate fraction with sodium dodecyl sulfate and centrifugation. RNA was then prepared from the ribosomal fraction by ethanol precipitation.
Mice were vaccinated intraperitoneally with 5.0 or 0.5 jig of the RNA preparation in 0.4 ml of Freund incomplete adjuvant (14) .
In vivo challenge and measurement of immunity. Immunized and nonimmunized CF-1 mice were challenged by intravenous injection of 1 mg (moist weight) of a fine suspension of the virulent H37Rv strain of Mycobacterium tuberculosis prepared as described for the H37Ra strain. The inbred C57B1/6 mice were challenged with 0.25 mg of H37Rv because they were more susceptible to tuberculosis (20) . A record was kept of the time of death of each animal. The number of mice surviving 30 days or longer in the immunized group was compared with the number of mice surviving 30 days or longer in the nonimmunized controls. The reliability and validity of this technique has been given by Youmans and Youmans (16).
Footpad tests. Tuberculin sensitivity to 2 jig of purified protein derivative (PPD) injected into the footpads of mice was measured as previously described (7, 18) .
Migration inhibition test. The migration inhibition test using mouse cells was performed as described in an earlier paper (7) . In the direct test, oil-induced peritoneal exudate cells were collected from nonimmunized and immunized mice, and the area of their migration was determined by projection and planimetry in the presence or absence of antigen. For the indirect test, supernatant fluids from splenic lymphocyte cultures were prepared and tested for the presence of MIF as previously described (7). Supernatant fluids also were dialyzed against physiological saline and then against distilled water. The dialysates were then lyophilized and stored at -70 C for later use. Samples to be tested were reconstituted in the complete tissue culture medium and sterilized by filtration. Results will be reported as percent migration in the presence of antigen compared with percent migration in the absence of antigen.
RESULTS
Effect of PPD on macrophage migration.
CF-1 mice which had been vaccinated with viable cells of the H37Ra strain of M. tuberculosis or with myc RNA preparations were highly VOL. 8, 1973 protected, as shown by concurrent studies (Table 1) . Similarly immunized mice were tested for footpad sensitivity to tuberculin. Only the mice immunized with viable H37Ra cells showed a significant degree of footpad swelling at 24 h as previously reported (7).
Peritoneal exudate cells were collected from nonimmunized, H37Ra-immunized, and myc RNA-immunized mice and tested for migration in the presence of PPD ( Table 2) . None of the PPD concentrations used had any effect on the migration of cells from nonimmunized or myc RNA-immunized mice. Migration of cells from H37Ra-immunized mice was significantly inhibited in the presence of PPD. Similar results were found using peritoneal exudate cells from C57B1/6 strain mice.
Effect of viable H37Ra cells. The addition of viable H37Ra cells to the migration chambers gave similar results (Table 3) . Peritoneal exudate cells from nonimmunized or myc RNAimmunized CF-1 or C57B1/6 mice migrated in t'he presence of the bacilli. Statistically significant inhibition of migration was detected only when viable H37Ra organisms were added to chambers containing peritoneal exudate cells from H37Ra-immunized mice.
Effect of myc RNA. myc RNA was added to the medium in the chambers containing peritoneal exudate cells from nonimmunized, H37Ra-immunized, and myc RNA-immunized mice. The addition of myc RNA had no inhibitory effect in any of the chambers (Table 4) . Fifty micrograms of myc RNA is the equivalent of 1 mg (moist weight) of the H37Ra microorgan- Inhibition obtained with lyophilized inhibitory supernatant fluids reconstituted to five times the original concentration was virtually identical to the inhibition seen when the supernatant fluids were fresh; the supernatant fluids which did not inhibit in their original form were still not inhibitory at five times their original concentration.
Intravenous stimulation. Antigen was injected intravenously into nonimmunized and immunized mice to determine the effect of in vivo administration of antigen on subsequent MIF production by spleen cells in vitro (7) . MIF production was found only with lymphocytes from H37Ra-immunized mice after intravenous injection of 100 to 150 Ag of PPD (Table 6 ). This fmding is consistent with our previously published results (7) . Injection of between 0.25 and 1.0 mg of viable H37Ra microorganisms resulted in in vitro MIF production by lymphocytes from H37Ra-immunized mice and by lymphocytes from myc RNA-immunized mice (Table 7) .
Positive footpad test reactions to tuberculin were found only with H37Ra-immunized mice, either before or after the intravenous injection of antigen. No positive footpad reactions to tuberculin were seen in nonimmunized or myc RNA-immunized mice either before or after the injection of the H37Ra organisms.
A sample (50 ug) of myc RNA was given intravenously to nonimmunized, H37Ra-immu- (18) to detect hypersensitivity to ribosomal and myc RNA fractions in mice and guinea pigs were unsuccessful. The hypersensitivity to the protein in the myc RNA preparations can play no role in the immune response because the protein can be removed in a number of ways without affecting the immunogenicity (12, 19 , and unpublished data). In this respect it is important to point out that hypersensitivity to RNA protein can be de- Evidence obtained in this study by using the murine migration inhibition technique supports the separation of delayed hypersensitivity to tuberculin and cellular immunity to infection because vaccination of mice with myc RNA does not result in production of tuberculin hypersensitivity. These observations strongly suggest that tuberculin hypersensitivity is not responsible for the cellular immunity to tuberculous infection.
